Trial Profile
Study of long term dose dependent agalsidase effects on kidney histology in Fabry disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2018
Price :
$35
*
At a glance
- Drugs Agalsidase alfa (Primary) ; Agalsidase beta (Primary)
- Indications Fabry's disease
- Focus Therapeutic Use
- 05 Jun 2018 New trial record